Japan Apheresis Market Insight
Published: 02 June 2026 | Report Format: Electronic (PDF)
The Japan apheresis market size is growing at a 5.90% CAGR, being propelled by the rising prevalence of hematological disorders, increasing adoption of plasma exchange therapies, and growing demand for advanced blood component separation technologies across Japan.
component separation technologies across Japan.
Japan Apheresis Market Insights Forecasts to 2035
- The Japan Apheresis Market Size Was Estimated at USD 157.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.90 % from 2025 to 2035
- The Japan Apheresis Market Size is Expected to Reach USD 263.5 Million by 2035
Notable Insights for Japan Apheresis Market
- By product type, the devices segment captured an estimated 51-54% share of the Japan apheresis market in 2025 driven by growing adoption of automated blood separation systems and therapeutic plasma exchange technologies at healthcare facilities.
- By procedure type, plasmapheresis held a roughly 41-44% share in the Japan apheresis market in 2025 due to growing demand for plasma-based products and treatment of neurological diseases and autoimmune disorders.
- The Ministry of Health, Labour and Welfare (MHLW) of Japan is promoting innovations in blood management and transfusion safety initiatives, thus boosting adoption of apheresis solutions in Japan.
- Growing investment in intelligent blood separation devices, automated blood collection equipment, plasma therapy services, and precision transfusion medicine solutions are fuelling growth of the apheresis industry in Japan.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- AI-Powered Blood Management Intelligence and Industry Insights
Decisions Advisors delivers AI-powered market intelligence, apheresis industry analysis, competitive benchmarking, emerging transfusion medicine trends, and actionable business insights to help organizations identify growth opportunities and make data-driven strategic decisions in the Japan apheresis market.
- Advanced Therapeutic Blood Separation Research Methodologies and Accurate Market Forecast Analysis
Our research combines primary and secondary research methodologies, expert interviews, proprietary analytical models, and data triangulation techniques to provide accurate apheresis market size estimation, CAGR analysis, therapeutic blood management demand forecasting, and reliable healthcare industry intelligence. - Comprehensive Transfusion Medicine Competitive Landscape and Growth Opportunity Analysis
We provide in-depth analysis of apheresis market dynamics, plasma exchange advancements, blood component collection trends, consumer behaviour patterns, competitive landscape evaluation, and investment opportunities across the Japan healthcare and therapeutic medical devices industry.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Apheresis market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Japan Apheresis Market
- Terumo Corporation
- Asahi Kasei Medical Co., Ltd.
- Fresenius Kabi AG
- Haemonetics Corporation
- Nikkiso Co., Ltd.
- SB-KAWASUMI LABORATORIES, INC.
- Kaneka Corporation
- B. Braun Melsungen AG
- Grifols S.A.
- Mallinckrodt plc
- Other
Recent Developments:
- In March 2025, Terumo Corporation launched a next-generation Spectra Optia Apheresis System integrating AI-based monitoring and enhanced process automation to improve therapeutic plasma exchange efficiency and patient safety in Japan.
Market Segmentation:
Japan Apheresis Market, By Product Type
- Devices
- Disposable Kits
Japan Apheresis Market, By Application
- Neurology
- Hematology
- Nephrology
- Oncology
- Autoimmune Disorders
- Others
Japan Apheresis Market, By End User
- Hospitals
- Blood Banks
- Specialty Clinics
- Research Institutes
- Others
Expert Views:
The Japan apheresis market is expected to witness substantial growth in the coming years owing to increasing prevalence of autoimmune and hematological disorders, rising adoption of plasma exchange therapies, advancements in automated blood separation technologies, and growing investments in transfusion medicine infrastructure. Moreover, expansion of AI-assisted therapeutic devices and precision healthcare systems is expected to provide ample growth opportunities for market players in Japan.
Author: Sanket and Pranali By Spherical Insights and Consulting